NCT03290612View on ClinicalTrials.gov

Vitamin C to Reduce Morning Cardiovascular Risk

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 13, 2018

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Cardiovascular Risk Factor
Interventions
DIETARY_SUPPLEMENT

Vitamin C

1.5g Ascorbic Acid

OTHER

Placebo

Inactive placebo to mimic 1.5g ascorbic acid.

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT03290612 - Vitamin C to Reduce Morning Cardiovascular Risk | Biotech Hunter | Biotech Hunter